Search
Treatment Settings
Various treatment formats, either in a live-in facility or through regular visits to a clinic, are designed for ongoing support, to help maintain recovery, and to prevent relapse.
The social context of drinking among LGBT+ people
Professor Carol Emslie and David Barbour discuss research on gender, identity and drinking, and the disproportionate impact of substance use in the LGBT+ community.
European Drug Report 2023: Trends and Developments
The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national...
Seminar on Youth Participation in Substance Use Prevention
To build an affluent society, the youth must be involved in prevention of substance - Director General, Department of Narcotics Control
Youth is the time for our brain to grow and develop. Using of substances at a young age affect brain...
No Smoking day commemoration by Pakistan Youth Organization
Pakistan Youth Organization has organized seminar on eve of international no Smoking day in collaboration with Freedom drug treatment & rehab Centre, Gujranwala Pakistan on 31st May, 2023 at Freedom Rehab. Sufi Muhammad Javed, Sana Ullah...
Highlights from the 2023 UNODC World Drug Report
ISSUP are pleased to present our Webinar on highlights from the 2023 edition of the UNODC World Drug Report.
Treatment and Prevention of Substance Use Disorders in the Workplace
ISSUP Kenya present their webinar on Workplace Substance Use.
MPSP speaks out against the decriminalization of drug possession for personal consumption
Dr. Mario Luiz Sarrubbo, Attorney General of the State of São Paulo, filed a memorial with the Federal Supreme Court (STF) with the position of the São Paulo Public Prosecutor's Office on the agenda that deals with the possible...
Exploring the impact of the COVID-19 pandemic on healthcare and substance use service access among women who inject drugs: a qualitative study
Abstract
Background
The COVID-19 pandemic disrupted healthcare and substance use services engagement, including primary and mental health services as well as residential and outpatient drug treatment. Women who inject drugs (WWID) face...
Comparative Effectiveness of Pharmacotherapies for the Risk of Attempted or Completed Suicide Among Persons With Borderline Personality Disorder
Abstract
Importance Suicidal behavior is a significant clinical concern in individuals with borderline personality disorder (BPD), but the effectiveness of pharmacotherapy on reducing suicide risk has remained unknown.
Objective To...
Continuum of Care in Recovery
ISSUP Botswana present their Webinar on Continuum of Care in Recovery.
Accounts of women identified as drinking at ‘high risk’ during pregnancy
Drinking alcohol during pregnancy is associated with Foetal Alcohol Spectrum Disorders (FASD), and women who drink at higher levels are more likely to have a baby with FASD.
Efforts to better understand and respond to ‘high risk’ drinking...
Webinar on Addiction Prevention for Youth
The International Society of Substance Use Professionals (ISSUP) Indonesia and the Indonesia International Training and Treatment Centre (ITTC) together hosted the second webinar on "Addiction Prevention for Youth" on Sunday, May 21, 2023...
Indonesia's INEP Plus Online Training
ISSUP Indonesia organized the Introduction to Evidence-Based Prevention (INEP) Online Course as a national-level training in Indonesia with 17 participants. The training, conducted by Dr.dr. Kristiana Siste, SpKJ, and Dr. Elvina K...
Treatment for drug and alcohol misuse should involve families and communities
Alcohol and other drug treatment are generally only provided for individuals, often away from their families. Treatment aims to improve well-being and reduce the harms of substance use and families and communities can play a significant...
FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder
For Immediate Release: May 23, 2023
Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...
FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder
For Immediate Release: May 24, 2023
Today, the U.S. Food and Drug Administration (FDA) approved the extended-release Brixadi (buprenorphine) subcutaneous (for use under the skin) injection to treat moderate to severe opioid use disorder...
Covering Substance Use and Addiction Responsibly
Stories about substance use and addiction can be among the thorniest that health and science reporters encounter. This topic carries a long history of marginalizing the people most directly affected. In addition, deeply ingrained societal misconceptions about substance use make it difficult to separate fact from fiction
Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention
Abstract
Substance use disorders (SUDs) are highly prevalent and impact individuals' health, well-being, and social functioning. Long-lasting changes in brain networks involved in reward, executive function, stress reactivity, mood, and...
Assessment of Medical Cannabis and Health-Related Quality of Life
Abstract
Importance The use of cannabis as a medicine is becoming increasingly prevalent. Given the diverse range of conditions being treated with medical cannabis, as well as the vast array of products and dose forms available, clinical...
SMART recovery for youth: a small, exploratory qualitative study examining the potential of a mutual-aid, peer support addictive behaviour change program for young people
Abstract
Background
SMART (Self-Management and Recovery Training) Recovery is a mutual-aid program informed by cognitive behaviour therapy and motivational interviewing that provides support for a range of addictive behaviours. SMART...